BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29744352)

  • 1. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.
    Dignass A; Farrag K; Stein J
    Int J Chronic Dis; 2018; 2018():9394060. PubMed ID: 29744352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.
    Rohr M; Brandenburg V; Brunner-La Rocca HP
    Eur J Med Res; 2023 Jan; 28(1):15. PubMed ID: 36617559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin.
    Goyal H; Mohanty S; Sharma M; Rani A
    Indian J Nephrol; 2017; 27(1):44-50. PubMed ID: 28182038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
    Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.
    Hamano T; Fujii N; Hayashi T; Yamamoto H; Iseki K; Tsubakihara Y
    Kidney Int Suppl (2011); 2015 Jun; 5(1):23-32. PubMed ID: 26097782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously].
    Fievet P; Coppin M; Brazier F; Lefèvre M; Stephan R; Demontis R
    Nephrol Ther; 2012 Feb; 8(1):41-6. PubMed ID: 21684231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Importance of Log Ferritin and Transferrin /Log Ferritin in Differentiating Iron Deficiency Anemia from Anemia of Chronic Disease in Rheumatoid Arthritis Patients.
    Abdel-Noor RA; Abu-Zaid MH; Elshweikh SA; Rabee ES; Khedr GE
    Egypt J Immunol; 2019 Jan; 26(1):141-150. PubMed ID: 31333004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Iron Status in Patients of Chronic Kidney Disease - A Study to Assess the Best Indicators Including Serum Transferrin Receptor Assay.
    Venkatesan M; Saxena S; Kumar A
    Indian J Nephrol; 2019; 29(4):248-253. PubMed ID: 31423058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action.
    Cacoub P; Choukroun G; Cohen-Solal A; Luporsi E; Peyrin-Biroulet L; Peoc'h K; Andrieu V; Lasocki S; Puy H; Trochu JN
    J Intern Med; 2022 Oct; 292(4):542-556. PubMed ID: 35466452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
    Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
    PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.
    Besarab A; Drueke TB
    Nephrol Dial Transplant; 2021 Jul; 36(8):1377-1383. PubMed ID: 32301986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-defining iron deficiency in patients with heart failure.
    Cuthbert JJ; Ransome N; Clark AL
    Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):667-681. PubMed ID: 35815543
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.